Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
type: MedicalStudy
description: A Phase 1, Open Label, Single Dose Study To Investigate The Pharmacokinetics, Safety And Tolerability Of Dalbavancin In Hospitalized Adolescents, Aged 12 Through 17 Years Receiving Standard Intravenous Anti-Infective Treatment For Bacterial Infections
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2008-09
end date: 2009-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00678106
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Pfizer
study subject: Bacterial Infections
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Bacterial Infections

AI Analytics
type: Organization